Related Experiment Video
Updated: Jul 9, 2025
09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
21.9K
Analysis of Matrix Metalloproteinase Activity and Inhibition in Cancer Spheroids
Anna M Knapinska1,2, Lillian Onwuha-Ekpete1, Gary Drotleff1,2
1Institute for Human Health & Disease Intervention (I-HEALTH) and Department of Chemistry & Biochemistry, Florida Atlantic University, Jupiter, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|December 1, 2023
Summary
This study introduces a "Hit Pick" method for rapid, data-efficient analysis of tumor invasion and membrane type 1 matrix metalloproteinase (MT1-MMP) activity in 3D models. The approach reduces data storage needs and monitors MT1-MMP inhibition in spheroids.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Tumor spheroids and organoids advance understanding of tumor growth, invasion, and drug screening.
- Monitoring 3D tumor invasion and protease activity generates extensive data, posing storage challenges.
Purpose of the Study:
- To develop a rapid, data-efficient method for analyzing tumor invasion and protease activity in 3D models.
- To quantitatively correlate tumor invasion with membrane type 1 matrix metalloproteinase (MT1-MMP) activity.
- To enable monitoring of MT1-MMP inhibition in spheroid systems.
Main Methods:
- Utilized the "Hit Pick" approach for quantitative analysis of tumor invasion.
- Correlated tumor invasion with membrane type 1 matrix metalloproteinase (MT1-MMP) activity.
- Assessed the method's ability to monitor MT1-MMP inhibition in spheroids.
Main Results:
- The "Hit Pick" method provides rapid quantitative analysis of tumor invasion and MT1-MMP activity.
- Significantly reduced data storage requirements compared to standard image analysis.
- Successfully monitored MT1-MMP inhibition in tumor spheroids.
Conclusions:
- The "Hit Pick" approach offers an efficient solution for analyzing 3D tumor invasion and MT1-MMP activity.
- This method facilitates high-throughput analysis and reduces data management burdens.
- Enables effective monitoring of therapeutic interventions targeting MT1-MMP.
